Aytu Biopharma (AYTU) Other Non Operating Income (2015 - 2026)

Aytu Biopharma (AYTU) has 12 years of Other Non Operating Income data on file, last reported at -$1.3 million in Q1 2026.

• Other Non Operating Income for Q1 2026 came in at -$1.3 million, down 155.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $434000.0 (down 81.48% YoY), and the FY2025 annual result was -$1.7 million, down 295.75% from the prior year.
• Other Non Operating Income slipped to -$1.3 million in Q1 2026 per AYTU's latest filing, from $190000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $8.3 million in Q2 2023 and troughed at -$1.3 million in Q1 2026.
• A 5-year average of $820764.7 and a median of $190000.0 in 2025 frame the typical range for Other Non Operating Income.
• On a YoY basis, Other Non Operating Income climbed as much as 5577.5% in 2022 and fell as far as 377.82% in 2022.
• A 5-year view of Other Non Operating Income shows it stood at -$1.2 million in 2022, then surged by 53.01% to -$577000.0 in 2023, then soared by 124.26% to $140000.0 in 2024, then soared by 35.71% to $190000.0 in 2025, then sank by 761.58% to -$1.3 million in 2026.
• Business Quant data shows AYTU's Other Non Operating Income at -$1.3 million in Q1 2026, $190000.0 in Q4 2025, and $201000.0 in Q3 2025.